| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a636d5acae75088e2bf65329dc8f30f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ba4beb5501dbc85be925f557f86edf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_904afeae2a94bcaeed286dcda3357f9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f74ab5be251cd9cd1f482cc1e324e7f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22b2f0c7115d6740ae1850eb45f75359 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0623 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0797 |
| filingDate |
2002-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ab7d1ee4d5156448e949029c05e2ced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1091427ea841c6df2911c0ff83507e85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6db2f2302caf2e8c3f165004b6637695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b94bccfe3e856e4077d63e608c543bce |
| publicationDate |
2003-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03018779-A1 |
| titleOfInvention |
Isolation of cells from neural cell populations using antibodies to fa1/dlk1 |
| abstract |
The present invention relates to the use of antibodies recognising Fetal Antigen-1 (FA1/dlk1) for the detection and isolation of cell subpopulations from neural cell populations, in particular from cell populations from the central nervous system. In one embodiment, the dopaminergic neurons in the Substantia nigra pars compacta are detected and separated from other cell populations in this region of the brain. In another embodiment, neural stem and progenitor cells are isolated from other more committed cells in the CNS. The isolated cells may be used for transplantation, drug screening, production of cell type specific antibodies, and gene discovery. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1304046-C |
| priorityDate |
2001-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |